Australia

See-Mode Technologies Receives FDA Clearance for Thyroid Ultrasound AI Analysis and Reporting Software

MELBOURNE, Australia, Sept. 17, 2024 /PRNewswire/ -- See-Mode Technologies, a global innovator in AI for ultrasound imaging, today announced the receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for their thyroid ultrasound analysis and reporting software. See-Mode's A...

2024-09-17 20:00 2111

Leadership Transition and Succession at Waterman Group

Nick Taylor to step down as CEO, Neil Humphrey named successor LONDON, Sept. 17, 2024 /PRNewswire/ -- After 42 years at Waterman, including 17 years as Chief Executive,Nick Taylor has decided to step down from the Waterman Group Plc Board on31st March 2025.

2024-09-17 19:36 3641

Antennova Releases Latest Data of CD73 Inhibitor ATN-037, including a DCR of 89.5%, in a Mini Oral at ESMO Congress 2024

* In patients with non-small cell lung cancer (NSCLC) or melanoma who had acquired resistance to checkpoint inhibitors (CPIs), ATN-037 in combination with KEYTRUDA®(pembrolizumab) demonstrated an overall response rate (ORR) of 21.1% and a disease control rate (DCR) of 89.5%. * Data from the...

2024-09-16 18:00 2723

RateMyAgent Launches Price Expert Badge To Highlight Top-Performing Agents

MELBOURNE, Australia, Sept. 12, 2024 /PRNewswire/ -- As one of the biggest shake-ups in the US property market comes into effect, review and reputation platformRateMyAgent is set to release powerful new data that will help prospective buyers identify top-performing agen...

2024-09-13 00:00 3676

SECuRE trial advances: No dose limiting toxicities and strong preliminary efficacy data in first multi-dose cohort

Highlights * Cohort 4 of the SECuRE trial is the first to assess multiple cycles of 67 Cu-SAR-bisPSMA at the highest dose of 12GBq. * The Safety Review Committee (SRC) assessed early data from the first 3 participants in cohort 4 who received 2 doses of67Cu-SAR-bisPSMA. Two of these participa...

2024-09-12 21:03 2411

Flex Space Evolution in India: Managed Solutions Propel Industry Growth and Expansion

BANGALORE, India, Sept. 9, 2024 /PRNewswire/ -- Table Space , in partnership with Cushman & Wakefield, has released a report,'From Flex to Managed - Evolution of the Flex Space Industry'

2024-09-09 14:39 3186

Harrison.ai launches world leading AI model to transform healthcare

Harrison.rad.1 significantly outperforms other major models on radiology tasks The new model is being made accessible to select healthcare professionals and regulators to open up the conversation on responsible use of AI in healthcare  SYDNEY, Sept. 4, 2024 /PRNewswire/ -- Healthcare AI technolog...

2024-09-04 21:30 2464

DataFeedWatch by Cart.com Becomes the First Feed Management Solution to Introduce Native AI

DataFeedWatch by Cart.com sets new industry standard by becoming the first feed management solution to introduce native AI HOUSTON, Sept. 3, 2024 /PRNewswire/ -- DataFeedWatch by Cart.com, a leading solution for managing and optimizing product feeds, has added full integration of AI to its feed ...

2024-09-03 18:00 2112

Manufacturers are embracing AI, reveals survey from Universal Robots

ODENSE, Denmark, Aug. 29, 2024 /PRNewswire/ -- Universal Robots (UR), the Danish collaborative robot (cobot) company, recently asked 1,200 manufacturers acrossNorth America and Europe how they use technology and how they plan to invest for the future. In the survey more than 50%responded

2024-08-29 15:48 2543

The Fifth Qingdao Multinationals Summit kicked off

QINGDAO, China, Aug. 28, 2024 /PRNewswire/ -- On the morning of August 28, the Fifth Qingdao Multinationals Summit, jointly organized by the Ministry of Commerce ofChina and the People's Government of Shandong Province, opened at the Qingdao International Conference Center with more than 800 pres...

2024-08-29 01:18 2215

Actinogen announces further positive results on depression in the XanCIDD phase 2a trial

Durable benefits previously reported for the MADRS depression scale are supported by the patient-reported outcome of PGI-S and new MADRS responder analyses that underscore benefit at week 10 with a 50% higher rate of remission of depression   SYDNEY, Aug. 26, 2024 /PRNewswire/ -- Actinogen Medic...

2024-08-26 20:30 2301

Clarity receives FDA Fast Track Designation for 64Cu-SAR-bisPSMA

SYDNEY, Aug. 22, 2024 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce that the U.S. Food and ...

2024-08-22 21:04 2742

TopBrand 2024 Top 500 Global Brands List released, with Apple as defending champion

GUANGZHOU, China, Aug. 19, 2024 /PRNewswire/ -- The 18th China Brand Festival was held duringAugust 7th-10th, 2024 in Guangzhou. The theme of this brand festival is "New Quality and Breakthrough". More than 8,000 guests gathered in the business capital over a millennium, to participate in paralle...

2024-08-20 18:35 3530

GREEN TECHNOLGY METALS (ASX: GT1) TRANSFORMATIONAL INVESTMENT & STRATEGIC FRAMEWORK AGREEMENT WITH ECOPRO

PERTH, Australia, Aug. 19, 2024 /PRNewswire/ -- Green Technology Metals Limited (ASX: GT1) (GT1 or the Company), a Canadian-focused multi-asset lithium business, is pleased to announce the execution of a Framework Agreement and Corporate Equity Investment with leading South Korean EV battery meta...

2024-08-20 13:06 2372

De Motu Cordis (DMC) Applauds ARS Pharma's FDA Approval of Neffy®, Expanding Patient Options to Needle-Free Epinephrine Delivery and Inspiring Confidence in Our Own Development Efforts

BRISBANE, Australia, Aug. 16, 2024 /PRNewswire/ -- De Motu Cordis (DMC) is pleased to acknowledge and enthusiastically commends the recent U.S. FDA approval of ARS Pharma's Neffy®, the first-ever needle-free intranasal epinephrine delivery device for the treatment of anaphylaxis. This groundbrea...

2024-08-16 18:00 5576

Actinogen announces achievement of clinically and statistically significant superiority of Xanamem® over placebo on depression in XanaCIDD phase 2a trial

There was a clinically meaningful and persistent improvement depression measured by the key secondary endpoint of MADRS.[1] The primary endpoint of superiority to placebo in a cognitive "attention composite" of three Cogstate computerized tests was not met with large improvements seen in both Xan...

2024-08-12 20:30 2543

Australia's Prestigious Darwin Aboriginal Art Fair returns Online for its 18th Year

DARWIN, Australia, Aug. 8, 2024 /PRNewswire/ -- The world-renowned Darwin Aboriginal Art Fair (DAAF) returns to Larrakia Country in Darwin,Australia, and is online fromAugust 9 to 11 (2024), celebrating Aboriginal and Torres Strait Islander art, design and culture.

2024-08-09 08:30 2836

Canadian Solar's e-STORAGE to Power 200 MWh Energy Storage Project in Southeastern Australia

GUELPH, ON, Aug. 7, 2024 /PRNewswire/ -- Canadian Solar Inc . (the "Company" or "Canadian Solar") (NASDAQ: CSIQ) today announced thate-STORAGE , which is part of the Company's majority-owned subsidiary CSI Solar Co., Ltd. ("CSI Solar"), has ...

2024-08-07 19:00 2855

QBIOTICS WELCOMES STEPHEN DOYLE AS CHIEF EXECUTIVE OFFICER

* Stephen Doyle has more than 24 years of experience in the global pharmaceutical industry, including leadership positions with companies such as Sanofi Aventis and Boehringer Ingelheim. He was most recently Chief Business Officer at Aslan Pharmaceuticals. * Mr Doyle brings extensive knowledg...

2024-08-05 19:00 2785

All-New Immersive Indigenous Experience, Sunrise Journeys, Premieres at Uluṟu

* Uluṟu's desert landscape brings an Indigenous artwork interpretation to life   * Immersive Indigenous laser, light and sound story-telling experience uses latest animation technology * Collaboration between renowned leading  Aṉangu artists and leading visual experience creator, Mandylights...

2024-07-31 21:15 2674
1 ... 6789101112 ... 49

Week's Top Stories